DailyDoctor Archive Specialties Get app
Back to the 2 November 2026 edition

Research · 03 of 05

Cephalosporin generation did not change pyelonephritis failure after ED discharge

Oral cephalosporins of different generations had similar 14-day failure in ED pyelonephritis; let culture and local resistance guide choice.

Design
Multicentre retrospective cohort
Population
1,147 adults discharged from 11 US EDs with pyelonephritis on an oral cephalosporin
Primary outcome
Treatment failure at 14 days
Effect
19.6% vs 17.6% vs 18.0% (first vs second vs third generation)

This retrospective cohort at 11 US academic emergency departments included 1,147 adults, over 85% women, discharged with pyelonephritis on an oral cephalosporin between 2023 and 2025. Most received cephalexin, cefuroxime or cefdinir.

Treatment failure at 14 days — recurrent symptoms, a return visit, a new antibiotic or admission — was 19.6% with first-generation, 17.6% with second-generation and 18.0% with third-generation agents. The differences were small and not significant.

Oral cephalosporins are often considered second-line for pyelonephritis because of concerns about urinary concentrations. This suggests generation matters less than expected, though one in five patients still needed further care.

It is observational, and dosing, local resistance and culture results were not standardised. In India, where resistance to oral cephalosporins in E. coli is common, local antibiograms should drive choice.

  • Base oral pyelonephritis treatment on local resistance patterns and the urine culture.
  • Send a urine culture before starting antibiotics in every patient discharged with pyelonephritis.
  • Arrange a check of culture results within 48–72 hours and switch if the organism is resistant.
  • Warn patients that about one in five need further care, and give clear return advice.

Why it matters

It challenges the assumption that only later-generation cephalosporins work for upper urinary infection.

Don't overread it

This was observational and from the US; it does not override local resistance data.

The statistics, in plain English

The difference between first and third generation was 1.6 points with a confidence interval of −3.4 to 6.5, which includes no difference and modest differences either way. The second-generation group was small (91 patients), so that comparison is less precise.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

sepsisshockventilationedops

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app